Clinical Trial

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-19
Trial Details
NCT Number NCT07565090
Lead Sponsor International AIDS Vaccine Initiative
Collaborators: Biomedical Advanced Research and Development Authority
Conditions Sudan Virus Disease
Enrollment 112 participants
Start Date 2026-05-08
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-18